Ruxolitinib
1 NDC across 1 manufacturer|0 Generic,1 Brand
Ruxolitinib is used to treat polycythemia vera and primary myelofibrosis, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
Ruxolitinib is available as 1 NDC from 1 manufacturer (0 generic, 1 brand), with NADAC prices from $34.00 to $34.00 per GM. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
1
0G / 1B
Manufacturers
1
competing in market
Price Spread
$34.00 – $34.00
per GM
7d Activity
avg +0.0% WoW · of 1 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing RUXOLITINIB
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
OPZELURA 1.5% CREAM | $33.9982 per GM | +0.02% |
Frequently Asked Questions
What is Ruxolitinib used to treat?
Ruxolitinib is used to treat polycythemia vera and primary myelofibrosis, per the National Library of Medicine's MED-RT classification.
How many Ruxolitinib products are on the market?
The Ruxolitinib drug market contains 1 NDC from 1 manufacturer — 0 generic and 1 brand product.
What is the price range for Ruxolitinib?
NADAC reference prices for Ruxolitinib range from $33.9982 to $33.9982 per GM.
Which manufacturers make Ruxolitinib?
1 manufacturer lists Ruxolitinib in NADAC. Ranked by number of NDCs, the largest are Incyte Corporation (1).
How has the price of Ruxolitinib changed recently?
Over the past 7 days, 2 Ruxolitinib NDCs rose and 0 fell, with a market-wide average change of +0.0%.